Ratings by Citi (Yigal Nochomovitz)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/15/2026 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/8/2026 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2026 | Shutterstock | SSTK | Upgrade | Buy (Neutral) |
13.18 (14.20) |
7.74% | Details | |
| 6/5/2026 | Shattuck Labs | STTK | Upgrade | Buy (Neutral) |
4.75 (6.44) |
35.58% | Details | |
| 6/3/2026 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2026 | Mirum Pharmaceuticals | MIRM | New Coverage | Buy (N/A) |
96.33 (123.77) |
28.49% | Details | |
| 5/26/2026 | Seaport Therapeutics | SPTX | New Coverage | Buy (N/A) |
17.50 (21.40) |
22.29% | Details | |
| 5/22/2026 | Summit Therapeutics plc | SMMT | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2026 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2026 | LENZ Therapeutics Inc | LENZ | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2026 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/7/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2026 | EyePoint Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 5/4/2026 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 4/24/2026 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2026 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2026 | Apellis Pharmaceuticals | APLS | Downgrade | Neutral (Buy) |
17.09 (41.03) |
140.08% | Details | |
| 3/26/2026 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 3/26/2026 | Sarepta Therapeutics | SRPT | Maintain | Sell (N/A) |
|
Details | ||
| 3/25/2026 | LENZ Therapeutics Inc | LENZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/24/2026 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2026 | Zenas Biopharma | ZBIO | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2026 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2026 | Shattuck Labs | STTK | Maintain | Neutral (N/A) |
|
Details | ||
| 3/10/2026 | Sarepta Therapeutics | SRPT | Maintain | Sell (N/A) |
|
Details | ||
| 3/6/2026 | EyePoint Inc. | EYPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2026 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 3/5/2026 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2026 | Arcturus Therapeutics | ARCT | Maintain | Neutral (N/A) |
|
Details | ||
| 3/3/2026 | SpyGlass Pharma | SGP | New Coverage | Buy (N/A) |
26.73 (21.18) |
-20.76% | Details | |
| 2/27/2026 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2026 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2026 | Krystal Biotech | KRYS | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2026 | Shattuck Labs | STTK | Maintain | Neutral (N/A) |
|
Details | ||
| 1/6/2026 | Krystal Biotech | KRYS | Upgrade | Buy (Neutral) |
244.71 (372.25) |
52.12% | Details | |
| 1/6/2026 | Arvinas Inc. | ARVN | Upgrade | Buy (Neutral) |
11.17 (8.00) |
-28.38% | Details | |
| 1/6/2026 | Arcturus Therapeutics | ARCT | Maintain | Neutral (N/A) |
|
Details | ||
| 1/5/2026 | Zenas Biopharma | ZBIO | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2025 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2025 | Ligand Pharma | LGND | New Coverage | Buy (N/A) |
184.67 (303.59) |
64.4% | Details | |
| 11/17/2025 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2025 | Arcturus Therapeutics | ARCT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2025 | BeOne Medicines | ONC | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2025 | Solid Biosciences | SLDB | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2025 | Ardelyx, Inc | ARDX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/29/2025 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2025 | Zenas Biopharma | ZBIO | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2025 | Arcturus Therapeutics | ARCT | Downgrade | Neutral (Buy) |
11.54 (6.88) |
-40.38% | Details | |
| 10/20/2025 | Summit Therapeutics plc | SMMT | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2025 | Shattuck Labs | STTK | Maintain | Neutral (N/A) |
|
Details | ||
| 10/13/2025 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 10/7/2025 | Arvinas Inc. | ARVN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/29/2025 | Merus N.V. | MRUS | Downgrade | Neutral (Buy) |
68.89 (90.00) |
30.64% | Details | |
| 9/25/2025 | Summit Therapeutics plc | SMMT | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2025 | Solid Biosciences | SLDB | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2025 | ProKidney Corp. | PROK | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2025 | Olema Pharmaceuticals | OLMA | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2025 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Sarepta Therapeutics | SRPT | Maintain | Sell (N/A) |
|
Details | ||
| 8/7/2025 | Lexicon Pharma | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/6/2025 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2025 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 7/24/2025 | Sarepta Therapeutics | SRPT | Maintain | Sell (N/A) |
|
Details | ||
| 7/24/2025 | Sarepta Therapeutics | SRPT | New Coverage | Sell (N/A) |
13.32 (16.85) |
26.5% | Details | |
| 7/18/2025 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2025 | Solid Biosciences | SLDB | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2025 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 7/10/2025 | Zenas Biopharma | ZBIO | Maintain | Buy (N/A) |
|
Details | ||
| 7/8/2025 | ProKidney Corp. | PROK | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2025 | Solid Biosciences | SLDB | New Coverage | Buy (N/A) |
4.74 (9.29) |
95.99% | Details | |
| 6/23/2025 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 6/10/2025 | LENZ Therapeutics Inc | LENZ | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2025 | LENZ Therapeutics Inc | LENZ | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2025 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/21/2025 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2025 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2025 | Arvinas Inc. | ARVN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/26/2025 | Summit Therapeutics plc | SMMT | Upgrade | Buy (Neutral) |
20.24 (14.01) |
-30.78% | Details | |
| 3/20/2025 | LENZ Therapeutics Inc | LENZ | Maintain | Buy (N/A) |
|
Details | ||
| 3/11/2025 | Arvinas Inc. | ARVN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/10/2025 | ProQR Therapeutics N.V. | PRQR | Upgrade | Buy (Neutral) |
1.94 (1.53) |
-21.13% | Details | |
| 3/7/2025 | ProQR Therapeutics N.V. | PRQR | Upgrade | Buy (Neutral) |
1.94 (1.94) |
0% | Details | |
| 3/6/2025 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2025 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 2/20/2025 | Candel Therapeutics Inc. | CADL | New Coverage | Buy (N/A) |
10.47 (9.79) |
-6.49% | Details | |
| 2/18/2025 | LENZ Therapeutics Inc | LENZ | Maintain | Buy (N/A) |
|
Details | ||
| 2/14/2025 | CRISPR Therapeutics | CRSP | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2025 | EyePoint Pharmaceuticals, Inc. | EYPT | New Coverage | Buy (N/A) |
8.68 (13.66) |
57.37% | Details | |
| 12/11/2024 | Cellectis | CLLS | Maintain | Buy (Buy) |
|
Details | ||
| 12/9/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2024 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2024 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2024 | Mersana | MRSN | New Coverage | Buy (N/A) |
2.63 (29.08) |
1005.7% | Details | |
| 11/11/2024 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2024 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2024 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2024 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 10/8/2024 | Zenas Biopharma | ZBIO | New Coverage | Buy (N/A) |
18.81 (25.87) |
37.53% | Details | |
| 10/2/2024 | Shattuck Labs | STTK | Downgrade | Neutral (Buy) |
35.37 (6.44) |
-81.79% | Details | |
| 9/27/2024 | Summit Therapeutics plc | SMMT | Downgrade | Neutral (Buy) |
22.81 (20.24) |
-11.27% | Details | |
| 9/27/2024 | Summit Therapeutics plc | SMMT | Downgrade | Neutral (Buy) |
22.81 (22.81) |
0% | Details | |
| 9/23/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2024 | ArriVent BioPharma | AVBP | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2024 | Summit Therapeutics plc | SMMT | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2024 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2024 | LENZ Therapeutics Inc | LENZ | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2024 | Summit Therapeutics plc | SMMT | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2024 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2024 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 6/17/2024 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 6/14/2024 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 6/4/2024 | Summit Therapeutics plc | SMMT | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2024 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2024 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 6/3/2024 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2024 | Summit Therapeutics plc | SMMT | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2024 | Calliditas Therapeutics | CALT | Downgrade | Neutral (Buy) |
37.94 (40.00) |
5.43% | Details | |
| 5/29/2024 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2024 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2024 | Summit Therapeutics plc | SMMT | New Coverage | Buy (N/A) |
4.47 (22.81) |
410.29% | Details | |
| 4/10/2024 | LENZ Therapeutics Inc | LENZ | New Coverage | Buy (N/A) |
20.42 (5.82) |
-71.5% | Details | |
| 3/21/2024 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | Harpoon Therapeutics | HARP | Downgrade | Neutral (Buy) |
22.93 (23.01) |
0.35% | Details | |
| 2/20/2024 | ArriVent BioPharma | AVBP | New Coverage | Buy (N/A) |
22.07 (34.00) |
54.06% | Details | |
| 2/14/2024 | Arvinas Inc. | ARVN | Downgrade | Neutral (Buy) |
47.77 (8.00) |
-83.25% | Details | |
| 1/30/2024 | Olema Pharmaceuticals | OLMA | New Coverage | Buy (N/A) |
11.62 (11.39) |
-1.98% | Details | |
| 12/20/2023 | Mirati Therapeutics | MRTX | Downgrade | Neutral (Buy) |
57.80 (58.70) |
1.56% | Details | |
| 12/20/2023 | MacroGenics | MGNX | Upgrade | Buy (Neutral) |
8.68 (4.81) |
-44.59% | Details | |
| 12/18/2023 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/12/2023 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/11/2023 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2023 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 12/5/2023 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2023 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2023 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2023 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2023 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/30/2023 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 10/24/2023 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2023 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 10/13/2023 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2023 | BeiGene, Ltd. | BGNE | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/24/2023 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2023 | CRISPR Therapeutics | CRSP | Upgrade | Buy (Neutral) |
47.20 (54.92) |
16.36% | Details | |
| 8/11/2023 | Galera Therapeutics | GRTX | Downgrade | Neutral (Buy) |
0.36 (0.15) |
-58.33% | Details | |
| 8/9/2023 | Mirati Therapeutics | MRTX | Upgrade | Buy (Neutral) |
27.80 (58.70) |
111.15% | Details | |
| 8/3/2023 | Coherus Biosciences | CHRS | Maintain | Buy (N/A) |
|
Details | ||
| 7/31/2023 | Reata Pharmaceuticals | RETA | Downgrade | Neutral (Buy) |
167.19 (172.36) |
3.09% | Details | |
| 7/24/2023 | Coherus Biosciences | CHRS | New Coverage | Buy (N/A) |
4.17 (1.50) |
-64.03% | Details | |
| 7/17/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/17/2023 | BeiGene, Ltd. | BGNE | New Coverage | Buy (N/A) |
198.17 (184.71) |
-6.79% | Details | |
| 6/26/2023 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 6/6/2023 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 5/31/2023 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2023 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2023 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2023 | ProQR Therapeutics N.V. | PRQR | Maintain | Neutral (N/A) |
|
Details | ||
| 5/25/2023 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 5/25/2023 | MacroGenics | MGNX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/25/2023 | Ideaya Biosciences | IDYA | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2023 | Rain Therapeutics | RAIN | Downgrade | Neutral (Buy) |
9.93 (1.93) |
-80.56% | Details | |
| 5/22/2023 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2023 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 5/18/2023 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2023 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2023 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy () |
|
Details | ||
| 5/5/2023 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 4/17/2023 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 3/29/2023 | Biomea Fusion Inc. | BMEA | Maintain | Buy (N/A) |
|
Details | ||
| 3/28/2023 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2023 | Rain Therapeutics | RAIN | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2023 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 3/15/2023 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2023 | Shattuck Labs | STTK | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2023 | Opthea Ltd. | OPT | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2023 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2023 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2023 | Biomea Fusion Inc. | BMEA | New Coverage | Buy (N/A) |
11.00 (1.32) |
-88% | Details | |
| 2/21/2023 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/27/2023 | Rain Therapeutics | RAIN | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2023 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2022 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/23/2022 | ProQR Therapeutics N.V. | PRQR | Maintain | Neutral (N/A) |
|
Details | ||
| 12/14/2022 | Cellectis | CLLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Mirati Therapeutics | MRTX | Downgrade | Neutral (Buy) |
49.59 (58.70) |
18.37% | Details | |
| 12/5/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2022 | Rigel Pharmaceuticals | RIGL | Upgrade | Buy (Neutral) |
0.68 (38.69) |
5589.71% | Details | |
| 11/28/2022 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | Rain Therapeutics | RAIN | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | MacroGenics | MGNX | Downgrade | Neutral (Buy) |
6.18 (8.68) |
40.45% | Details | |
| 11/23/2022 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 11/23/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2022 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/22/2022 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2022 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2022 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Arcturus Therapeutics | ARCT | Upgrade | Buy (Neutral) |
21.69 (11.54) |
-46.8% | Details | |
| 10/14/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | ProKidney | PROK | New Coverage | Buy (N/A) |
10.25 (1.83) |
-82.15% | Details | |
| 9/22/2022 | Gracell Biotechnologies Inc | GRCL | New Coverage | Buy (N/A) |
2.30 (10.25) |
345.65% | Details | |
| 9/16/2022 | Opthea Ltd. | OPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/16/2022 | Innate Pharma S.A. | IPHA | Maintain | Buy (N/A) |
|
Details | ||
| 8/29/2022 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 8/29/2022 | Aerie Pharma | AERI | Downgrade | Neutral (Buy) |
15.10 (15.25) |
0.99% | Details | |
| 8/26/2022 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2022 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2022 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 8/26/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Cellectis | CLLS | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 8/18/2022 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2022 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2022 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2022 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2022 | Arcturus Therapeutics | ARCT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/9/2022 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2022 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2022 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 7/20/2022 | Atara Biotherapeutics | ATRA | Downgrade | Sell (Neutral) |
3.64 (10.51) |
188.74% | Details | |
| 7/19/2022 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2022 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2022 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2022 | Rigel Pharmaceuticals | RIGL | Downgrade | Neutral (Buy) |
1.76 (0.68) |
-61.36% | Details | |
| 6/1/2022 | Shattuck Labs | STTK | New Coverage | Buy (N/A) |
2.72 (6.44) |
136.76% | Details | |
| 5/20/2022 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 5/20/2022 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2022 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 5/19/2022 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 5/16/2022 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 5/12/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2022 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 5/10/2022 | Ultragenyx Pharma | RARE | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Atara Biotherapeutics | ATRA | Downgrade | Neutral (Buy) |
6.92 (3.64) |
-47.4% | Details | |
| 4/21/2022 | Arcturus Therapeutics | ARCT | Downgrade | Neutral (Buy) |
25.26 (21.69) |
-14.13% | Details | |
| 4/8/2022 | Innate Pharma S.A. | IPHA | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2022 | Caribou Biosciences Inc. | CRBU | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2022 | Imara Inc. | IMRA | Downgrade | Neutral (Buy) |
1.63 (17.43) |
969.33% | Details | |
| 3/16/2022 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2022 | NuCana | NCNA | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2022 | MacroGenics | MGNX | Upgrade | Buy (Neutral) |
9.67 (4.81) |
-50.26% | Details | |
| 2/14/2022 | ProQR Therapeutics N.V. | PRQR | Downgrade | Neutral (Buy) |
5.64 (1.94) |
-65.6% | Details | |
| 12/21/2021 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2021 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2021 | Calliditas Therapeutics | CALT | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2021 | Syndax Pharmaceuticals | SNDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2021 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2021 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 12/3/2021 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 11/30/2021 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 11/24/2021 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/19/2021 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2021 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2021 | Caribou Biosciences Inc. | CRBU | Upgrade | Buy (Neutral) |
20.52 (1.68) |
-91.81% | Details | |
| 11/9/2021 | Fate Therapeutics | FATE | Upgrade | Buy (Neutral) |
61.42 (2.10) |
-96.58% | Details | |
| 10/11/2021 | Merus N.V. | MRUS | Maintain | Buy (N/A) |
|
Details | ||
| 9/28/2021 | Harpoon Therapeutics | HARP | Upgrade | Buy (Neutral) |
7.96 (23.01) |
189.07% | Details | |
| 9/28/2021 | Puma Biotechnology | PBYI | Upgrade | Buy (Neutral) |
6.82 (8.11) |
18.91% | Details | |
| 9/22/2021 | Innate Pharma S.A. | IPHA | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2021 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 8/30/2021 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/25/2021 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2021 | Caribou Biosciences Inc. | CRBU | New Coverage | Neutral (N/A) |
26.48 (1.68) |
-93.66% | Details | |
| 8/13/2021 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Neutral (Buy) |
37.92 (38.22) |
0.79% | Details | |
| 7/23/2021 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 6/28/2021 | Unity Biotechnology Inc | UBX | Upgrade | Buy (Sell) |
4.34 (0.20) |
-95.39% | Details | |
| 6/14/2021 | CRISPR Therapeutics | CRSP | Upgrade | Neutral (Sell) |
123.71 (54.92) |
-55.61% | Details | |
| 6/8/2021 | Harpoon Therapeutics | HARP | Downgrade | Neutral (Buy) |
15.27 (7.96) |
-47.87% | Details | |
| 6/7/2021 | Merus N.V. | MRUS | Upgrade | Buy (Neutral) |
20.68 (68.89) |
233.12% | Details | |
| 6/4/2021 | Mirati Therapeutics | MRTX | Upgrade | Buy (Neutral) |
154.86 (49.59) |
-67.98% | Details | |
| 5/26/2021 | Puma Biotechnology | PBYI | Maintain | Neutral (N/A) |
|
Details | ||
| 5/25/2021 | Syndax Pharmaceuticals | SNDX | New Coverage | Buy (N/A) |
17.69 (21.31) |
20.46% | Details | |
| 5/21/2021 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 5/21/2021 | Arcus Biosciences | RCUS | Maintain | Buy (N/A) |
|
Details | ||
| 5/20/2021 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2021 | Imara Inc. | IMRA | New Coverage | Buy (N/A) |
7.46 (17.43) |
133.65% | Details | |
| 5/11/2021 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 5/6/2021 | Ultragenyx Pharma | RARE | Upgrade | Buy (Neutral) |
101.85 (30.77) |
-69.79% | Details | |
| 3/25/2021 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2021 | Ovid Therapeutics Inc | OVID | Maintain | Neutral (N/A) |
|
Details | ||
| 3/2/2021 | Atara Biotherapeutics | ATRA | Upgrade | Buy (Neutral) |
17.10 (10.51) |
-38.54% | Details | |
| 3/1/2021 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/16/2021 | Unity Biotechnology Inc | UBX | Downgrade | Sell (Neutral) |
8.28 (0.20) |
-97.58% | Details | |
| 2/11/2021 | Fate Therapeutics | FATE | Downgrade | Neutral (Buy) |
103.31 (2.10) |
-97.97% | Details | |
| 1/28/2021 | Zymeworks | ZYME | Upgrade | Buy (Neutral) |
44.06 (24.15) |
-45.19% | Details | |
| 1/25/2021 | Zymeworks | ZYME | Downgrade | Neutral (Buy) |
52.16 (24.15) |
-53.7% | Details | |
| 1/15/2021 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 1/14/2021 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2021 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2020 | Arvinas Inc. | ARVN | Maintain | Buy (N/A) |
|
Details | ||
| 12/14/2020 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 12/9/2020 | Atara Biotherapeutics | ATRA | Downgrade | Neutral (Buy) |
26.23 (17.10) |
-34.81% | Details | |
| 12/8/2020 | Lexicon Pharmaceuticals | LXRX | Upgrade | Buy (Neutral) |
1.58 (2.55) |
61.39% | Details | |
| 12/7/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2020 | Ovid Therapeutics Inc | OVID | Downgrade | Neutral (Buy) |
6.84 (2.55) |
-62.72% | Details | |
| 11/25/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2020 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2020 | Cellectis | CLLS | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2020 | Fate Therapeutics | FATE | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2020 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/6/2020 | Arcturus Therapeutics | ARCT | New Coverage | Buy (N/A) |
49.97 (6.88) |
-86.23% | Details | |
| 9/18/2020 | Mirati Therapeutics | MRTX | Downgrade | Neutral (Buy) |
161.97 (58.70) |
-63.76% | Details | |
| 8/19/2020 | Cellectis | CLLS | Upgrade | Buy (Buy) |
17.22 (2.83) |
-83.57% | Details | |
| 8/18/2020 | Unity Biotechnology Inc | UBX | Downgrade | Neutral (Buy) |
12.43 (0.20) |
-98.39% | Details | |
| 8/17/2020 | Imara Inc. | IMRA | Upgrade | Buy (Neutral) |
20.61 (17.43) |
-15.43% | Details | |
| 8/11/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2020 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2020 | MacroGenics | MGNX | Downgrade | Neutral (Buy) |
26.75 (4.81) |
-82.02% | Details | |
| 7/13/2020 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Harpoon Therapeutics | HARP | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2020 | Imara Inc. | IMRA | Downgrade | Neutral (Buy) |
34.23 (17.43) |
-49.08% | Details | |
| 6/26/2020 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Unity Biotechnology Inc | UBX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Galera Therapeutics | GRTX | Maintain | Buy (N/A) |
|
Details | ||
| 6/5/2020 | Eiger BioPharma | EIGR | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 6/2/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2020 | Arvinas Inc. | ARVN | Upgrade | Buy (Neutral) |
44.85 (8.00) |
-82.16% | Details | |
| 5/8/2020 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 5/5/2020 | Portola Pharmaceuticals | PTLA | Downgrade | Neutral (Buy) |
7.76 (18.03) |
132.35% | Details | |
| 4/28/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/28/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 4/23/2020 | Atara Biotherapeutics | ATRA | Upgrade | Buy (Neutral) |
8.00 (10.51) |
31.38% | Details | |
| 4/6/2020 | Imara Inc. | IMRA | New Coverage | Buy (N/A) |
15.75 (17.43) |
10.67% | Details | |
| 3/31/2020 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 3/16/2020 | Lexicon Pharmaceuticals | LXRX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/12/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2020 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 3/2/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2020 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2020 | Aerie Pharma | AERI | Maintain | Buy (N/A) |
|
Details | ||
| 2/12/2020 | Ardelyx, Inc | ARDX | New Coverage | Buy (N/A) |
7.33 (5.55) |
-24.28% | Details | |
| 1/28/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/24/2020 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 1/21/2020 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 1/13/2020 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 1/13/2020 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 1/9/2020 | Applied Therapeutics | APLT | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 1/7/2020 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2019 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2019 | Aerie Pharma | AERI | New Coverage | Buy (N/A) |
21.92 (15.25) |
-30.43% | Details | |
| 12/18/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 12/2/2019 | Galera Therapeutics | GRTX | New Coverage | Buy (N/A) |
12.53 (0.15) |
-98.8% | Details | |
| 11/19/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | Ovid Therapeutics Inc | OVID | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | CRISPR Therapeutics | CRSP | Maintain | Sell (N/A) |
|
Details | ||
| 11/8/2019 | Lexicon Pharmaceuticals | LXRX | Downgrade | Neutral (Buy) |
3.88 (2.55) |
-34.28% | Details | |
| 11/7/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 11/7/2019 | MacroGenics | MGNX | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2019 | Reata Pharmaceuticals | RETA | Maintain | Buy (N/A) |
|
Details | ||
| 10/11/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 10/9/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/24/2019 | Ovid Therapeutics Inc | OVID | Maintain | Buy (N/A) |
|
Details | ||
| 9/17/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 9/10/2019 | Translate Bio | TBIO | Maintain | Buy (N/A) |
|
Details | ||
| 9/4/2019 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2019 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 8/21/2019 | NuCana | NCNA | Maintain | Buy () |
|
Details | ||
| 8/21/2019 | Synlogic Inc. | SYBX | Downgrade | Sell (Buy) |
4.83 (0.56) |
-88.41% | Details | |
| 8/12/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2019 | Atara Biotherapeutics | ATRA | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 8/7/2019 | Mirati Therapeutics | MRTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/5/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 7/30/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/3/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (Buy) |
|
Details | ||
| 6/26/2019 | Aldeyra Therapeutics | ALDX | Maintain | Buy (N/A) |
|
Details | ||
| 6/26/2019 | Eiger BioPharma | EIGR | New Coverage | Buy (N/A) |
10.61 (1.73) |
-83.69% | Details | |
| 6/13/2019 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2019 | Puma Biotechnology | PBYI | Maintain | Neutral (N/A) |
|
Details | ||
| 6/5/2019 | Arvinas Inc. | ARVN | Downgrade | Neutral (Buy) |
20.05 (44.85) |
123.69% | Details | |
| 6/4/2019 | Mirati Therapeutics | MRTX | Upgrade | Buy (Neutral) |
89.20 (58.70) |
-34.19% | Details | |
| 6/4/2019 | Atara Biotherapeutics | ATRA | Upgrade | Neutral (Sell) |
22.21 (10.51) |
-52.68% | Details | |
| 5/24/2019 | Acceleron Pharma | XLRN | Maintain | Buy (N/A) |
|
Details | ||
| 5/24/2019 | Cellectis | CLLS | New Coverage | Neutral (N/A) |
18.34 (2.83) |
-84.57% | Details | |
| 5/24/2019 | Acceleron Pharma | XLRN | New Coverage | Buy (N/A) |
43.25 (178.75) |
313.29% | Details | |
| 5/24/2019 | Arcus Biosciences | RCUS | New Coverage | Buy (N/A) |
9.52 (31.00) |
225.63% | Details | |
| 5/15/2019 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2019 | Mirati Therapeutics | MRTX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/10/2019 | Puma Biotechnology | PBYI | Downgrade | Neutral (Buy) |
30.02 (6.82) |
-77.28% | Details | |
| 5/2/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 3/21/2019 | Merus N.V. | MRUS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/20/2019 | Akebia Therapeutics | AKBA | New Coverage | Neutral (N/A) |
8.17 (1.14) |
-86.05% | Details | |
| 3/15/2019 | Merus N.V. | MRUS | Maintain | Neutral (N/A) |
|
Details | ||
| 3/15/2019 | Ovid Therapeutics Inc | OVID | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2019 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 3/6/2019 | Chimerix | CMRX | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2019 | Portola Pharmaceuticals | PTLA | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2019 | Mirati Therapeutics | MRTX | Downgrade | Neutral (Buy) |
72.80 (89.20) |
22.53% | Details | |
| 3/1/2019 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2019 | Ultragenyx Pharma | RARE | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2019 | ProQR Therapeutics N.V. | PRQR | Maintain | Buy (N/A) |
|
Details | ||
| 2/7/2019 | MacroGenics | MGNX | Upgrade | Buy (Sell) |
11.11 (4.81) |
-56.71% | Details | |
| 2/4/2019 | MacroGenics | MGNX | Downgrade | Sell (Neutral) |
11.73 (11.11) |
-5.29% | Details | |
| 1/24/2019 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 1/22/2019 | CRISPR Therapeutics | CRSP | Downgrade | Sell (Neutral) |
37.13 (54.92) |
47.91% | Details | |
| 1/18/2019 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/2/2019 | Merus N.V. | MRUS | Maintain | Neutral (N/A) |
|
Details | ||
| 12/6/2018 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2018 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 12/4/2018 | Aldeyra Therapeutics | ALDX | New Coverage | Buy (N/A) |
8.97 (1.83) |
-79.6% | Details | |
| 11/27/2018 | Zymeworks | ZYME | Maintain | Buy (N/A) |
|
Details | ||
| 11/27/2018 | LOXO | Maintain | Buy (N/A) |
|
Details | |||
| 11/16/2018 | Rigel Pharmaceuticals | RIGL | Maintain | Buy (N/A) |
|
Details | ||
| 11/15/2018 | ProQR Therapeutics N.V. | PRQR | New Coverage | Buy (N/A) |
18.67 (1.53) |
-91.81% | Details | |
| 11/9/2018 | Chimerix | CMRX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/8/2018 | Ultragenyx Pharma | RARE | Upgrade | Neutral (Sell) |
54.34 (30.77) |
-43.38% | Details | |
| 11/7/2018 | Portola Pharmaceuticals | PTLA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2018 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2018 | Lexicon Pharmaceuticals | LXRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/29/2018 | Ultragenyx Pharma | RARE | Maintain | Sell (N/A) |
|
Details | ||
| 10/22/2018 | Arvinas Inc. | ARVN | New Coverage | Buy (N/A) |
15.56 (20.05) |
28.86% | Details | |
| 9/28/2018 | Apellis Pharmaceuticals | APLS | Maintain | Buy (N/A) |
|
Details | ||
| 9/18/2018 | Puma Biotechnology | PBYI | Maintain | Buy (N/A) |
|
Details | ||
| 9/14/2018 | Zai Lab | ZLAB | Maintain | Buy (N/A) |
|
Details | ||
| 9/5/2018 | Synlogic Inc. | SYBX | Maintain | Buy (N/A) |
|
Details | ||
| 8/27/2018 | Rigel Pharmaceuticals | RIGL | New Coverage | Buy (N/A) |
2.80 (38.69) |
1281.79% | Details | |
| 8/24/2018 | CRISPR Therapeutics | CRSP | Maintain | Neutral (N/A) |
|
Details | ||
| 8/24/2018 | Synlogic Inc. | SYBX | Upgrade | Buy (Neutral) |
7.91 (4.83) |
-38.94% | Details |
